Skip to main content
. 2021 Feb 10;7(1):veab011. doi: 10.1093/ve/veab011

Figure 2.

Figure 2.

Fixed treatment interval and explicit testing impact on MPSPVL in Model 1A. The fixed interval between infection and treatment and the mean explicit testing interval were varied from 1 to 6 years. Treatment began in year 0. Each symbol is the mean of sixteen simulations. Bars show 95% confidence intervals. (a) Mean population SPVLs of those infected in years 20–40 in simulations using fixed interval treatment initiation. (b) Mean population SPVLs of those infected in years 20–40 in simulations using explicit testing treatment initiation.